Lab Automation Market by Product (Equipment, Services, Software), Automation Type (Modular Automation, Total Lab Automation), Application, End User - Global Forecast 2024-2030

Lab Automation Market by Product (Equipment, Services, Software), Automation Type (Modular Automation, Total Lab Automation), Application, End User - Global Forecast 2024-2030

The Lab Automation Market size was estimated at USD 5.83 billion in 2023 and expected to reach USD 6.29 billion in 2024, at a CAGR 8.30% to reach USD 10.20 billion by 2030.

Lab automation includes the utilization of technology to perform experiments and procedures in the laboratory with minimal human intervention. It encompasses a variety of platforms, software, and tools to enhance efficiency, accuracy, and productivity in laboratory settings. The purpose is to automate mundane, repetitive tasks, allowing scientists and researchers to focus on more complex and innovative work. Increased demand for high-throughput screening that involves rapidly conducting millions of chemical, genetic, or pharmacological tests is driving the growth of the lab automation market. Growing emphasis on data accuracy and reproducibility with the rising adoption of digital technologies across laboratories is driving the growth of the market. The high initial investment required for setting up an automated laboratory system hampers the market growth. Continuous integration of advanced technologies to improve the efficiency of lab automation solutions is expected to create opportunities for market growth. The evolution of technologies such as liquid handling systems, robotics, and data analytics tools that contribute to the efficiency of lab automation systems improve precision, and reduce the possibilities of human error is expected to create a platform for market growth.

Regional Insights

In the Americas, the lab automation market is experiencing robust growth, primarily driven by advanced healthcare infrastructure, significant investment in R&D by pharmaceutical and biotech companies, and a strong focus on innovation. The United States stands out as a pivotal market, owing to its large-scale adoption of automated systems in diagnostics, drug discovery, and genomic research. Government initiatives and funding in life sciences research further fuel the market's expansion in this region. The APAC region is witnessing rapid growth in the lab automation market, attributed to its expanding pharmaceutical sector, rising investments in healthcare infrastructure, and growing emphasis on research and development. Countries including, China, Japan, and India are at the forefront, leveraging lab automation technologies to cater to their vast populations’ healthcare needs. The region's commitment to adopting new technologies and increasing healthcare expenditure are key factors propelling the market forward. The lab automation market in EMEA is diversified and has a strong presence in developed and emerging economies. Europe leads in this region, driven by its well-established pharmaceutical and biotech industries and substantial government and private funding for research and innovation. The Middle East and Africa are gradually catching up, with an increasing focus on enhancing healthcare services and research capabilities. The growth in this region is also supported by a growing awareness of the benefits of lab automation in improving diagnostic accuracy and efficiency.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Lab Automation Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increased need for high-throughput screening across pharmaceutical companies
Growing emphasis on data accuracy and reproducibility by research centers
Rising government support for the adoption of automation and digital technologies across the pharmaceutical sector

Market Restraints

High Initial Investment associated with the integration of lab automation solutions

Market Opportunities

Continuous integration of novel technologies in lab automation solutions that improve efficiency
Stringent government regulations around laboratory practices and data integrity

Market Challenges

Data security and privacy issues with lab automation solutions

Market Segmentation Analysis

Product: Growing usage of automated liquid handlers to manipulate liquids precisely
End User: High potential of lab automation solutions across biotechnology & pharmaceutical companies for streamlining workflows

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Lab Automation Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Lab Automation Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Agilent Technologies Inc. Launches Revolutionary ADS 2 for Enhanced Laboratory Efficiency

Agilent Technologies Inc. introduced the Advanced Dilution System (ADS 2), a revolutionary addition designed to significantly boost the efficiency of laboratory workflows in analytical testing. As a seamless integration to Agilent's suite of instruments and software, the ADS 2 is poised to transform auto dilution processes with its innovative flow path technology, ensuring rapid analysis with consistent and traceable data. Aimed at optimizing routine testing across food, environmental, and pharmaceutical sectors, advanced materials research such as battery development, the ADS 2 underscores Agilent's commitment to advancing laboratory automation solutions.

Carbon Unveils Its Automatic Operation Suite to Enhance Efficiency and Precision

Carbon introduced its Automatic Operation (AO) suite, a collection of solutions aimed at redefining dental lab automation. Developed to cater specifically to the unique demands of dental laboratories, the AO suite elevates operational efficiency and precision, significantly diminishing print turnover times and labor involved in processing. These tools collectively promise a seamless integration into existing lab workflows, showcasing Carbon's dedication to continuous innovation and customer-focused solutions in additive manufacturing.

Strategic Partnership Elevates European Lab Automation Landscape

GC Biotech announced its new exclusive distribution partnership with Genie Life Sciences to distribute, service, and support Genie Life Sciences' innovative automation products across nearly all European countries. Central to this partnership is the integration of Genie's cutting-edge LabMate robot and LabOS software into GC Biotech's offerings. This fusion promises to revolutionize laboratory operations by simplifying the management of multiple instruments through a single cloud-based platform, catering to a broad spectrum of scientific endeavors such as genomics, proteomics, and drug discovery.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Lab Automation Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Lab Automation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuris Instruments, Agilent Technologies, Inc., Aurora Biomed Inc., Automata Technologies Limited, Awareness Technology, Inc., Azenta Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biochrom by Harvard Bioscience, Inc., Biohit Oyj, bioMérieux SA, BMG Labtech GmbH, Brooks Automation, Inc., Bruker Corporation, Byonoy GmbH, Cerner Corporation by Oracle Corporation, Corning Incorporated, CTK Biotech, Inc., Danaher Corporation, Dendi, Inc., Dynex Technologies, Inc., Endress+Hauser Group Services AG, Enzo Life Sciences, Inc., Eppendorf SE, F. Hoffmann-La Roche Ltd., Formulatrix, Inc., General Biologicals Corporation, Hamilton Company, Hudson Robotics, Inc., JASCO Corporation, Labguru by Biodata Inc, LabVantage Solutions Inc., LabWare, Inc., LigoLab Information System, Mecademic Robotics, Merck KGaA, Orchard Software Corporation, PerkinElmer Inc., Promega Corporation, QIAGEN GmbH, Rayto Life and Analytical Sciences Co.,Ltd., Siemens AG, Strateos, Inc., Synchron Lab Automation by MolGen, Tecan Trading AG, Thermo Fisher Scientific Inc., Uncountable Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Lab Automation Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Equipment
Automated Liquid Handlers
Automated Plate Handlers
Automated Storage & Retrieval
Robotic Arms
Services
Installation & Commissioning
Maintenance & Upgrades
System Integration
Software
Chromatography Data System
Electronic Lab Notebook
Laboratory Information Management System
Laboratory Information System
Scientific Data Management System
Automation Type
Modular Automation
Total Lab Automation
Application
Clinical Diagnostics
Drug Discovery
Genomics
Microbiology
Proteomics
End User
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year